Shuli Svetitsky

Shuli Svetitsky

Auto-generated profile, based on publicly available information

Shuli Svetitsky

Imperial College Healthcare NHS Trust Renal and Transplant Centre, Barts Health NHS Trust, London, United Kingdom of Great Britain and Northern Ireland

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Transplantation Proceedings
Verified
Journal Article
Closed access
SSS. Svetitsky
S. Svetitsky
RBR. Baruch
R. Baruch
ISI.F. Schwartz
I.F. Schwartz
DSDoron Schwartz
Doron Schwartz
RNR. Nakache
R. Nakache
AGA. Grupper
A. Grupper

9 October 2023 in Obstetric Medicine
Verified
Journal Article
Closed access
SSShuli Svetitsky
Shuli Svetitsky
LLLiz Lightstone
Liz Lightstone
KWKate Wiles
Kate Wiles
Background: Obstetric and kidney outcomes following detection of nephrotic-range proteinuria in early pregnancy have not been well described. Methods: A retrospective cohort study of chronic kidney disease (CKD) in pregnancy between 2008 and 2018. Outcomes in those with nephrotic-range proteinuria before 20 weeks’ gestation were compared to those without nephrotic-range proteinuria. Results: The study included 37 women with nephrotic-range proteinuria and 62 women without. Pre-pregnancy estimated glomerular filtration rate (eGFR) was similar. Nephrotic-range proteinuria was associated with higher rates of preterm (odds ratio [OR] 1.77, 95% confidence interval [CI]: 1.07–2.92) and early preterm delivery (OR 2.63, 95% CI: 1.12–6.2), and with a requirement for renal replacement therapy at 3 years post-partum (OR 10.72, 95% CI: 2.58–44.47). Tubulointerstitial scarring on kidney biopsy was associated with early preterm delivery and progression to advanced CKD, independent of pre-pregnancy eGFR. Conclusion: Compared to CKD without nephrotic-range proteinuria, nephrotic-range proteinuria early in pregnancy is associated with higher rates of pre-term delivery and progression to advanced CKD.